Skip to main content
. 2016 Apr 7;20:83. doi: 10.1186/s13054-016-1267-8

Table 1.

Demographic and clinical characteristics of the 206 patients with or without subsequent antibiotic de-escalation

Characteristic De-escalation (n = 110) No de-escalation (n = 96) Escalation (n = 65) No change (n = 31)
Male sex, n (%) 61 (55) 56 (58) 35 (54) 21 (68)
Age, years, median (IQR) 61 (47–72) 66 (51–75)a 63 (47–75) 70 (58–77)
Comorbidities
 Fatal underlying disease 30 (27) 32 (33) 21 (32) 11 (35)
 Cancer, n (%) 37 (34) 36 (38) 23 (35) 13 (42)
 Diabetes, n (%) 17 (15) 15 (16) 9 (14) 6 (19)
Time since initial surgery, days, median (IQR) 7 (5–12) 7 (4–10) 6 (3–9) 8 (5–10)
Antibiotic therapy before reoperation, n (%) 73 (66) 68 (71) 47 (72) 21 (68)
Broad-spectrum interim antibiotic, n (%) 34 (31) 37 (39) 27 (42) 10 (32)
Intraoperative diagnosis
 Anastomotic leakage, n (%) 45 (41) 27 (28) 19 (29) 8 (26)
 Perforation or ischemia, n (%) 33 (30) 36 (38) 20 (31) 16 (52)a#
 Purulent collection, n (%) 19 (17) 17 (18) 13 (20) 4 (13)
 No cause, n (%) 19 (17) 20 (21) 15 (23) 5 (16)
Contamination below transverse mesocolon, n (%) 82 (75) 74 (77) 50 (77) 24 (77)
Characteristics at the time of ICU admission
 Bacteremia, n (%) 26 (24) 17 (18) 14 (22) 3 (10)
 SAPS II score, median (IQR) 45 (34–54) 47 (35–57) 44 (34–56) 51 (42–61)a#
 SOFA score, median (IQR) 7 (4–9) 8 (4–10) 7 (4–9) 9 (6–10)
 Hemodynamic failureb, n (%) 65 (59) 65 (68) 41 (63) 24 (77)
 Respiratory failureb, n (%) 54 (49) 40 (42) 26 (40) 14 (45)
 Renal failureb, n (%) 21 (19) 18 (19) 13 (20) 5 (16)

IQR interquartile range, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment

Patients without de-escalation were also analyzed in terms of subsequent antibiotic escalation or no change. Results are expressed as number and proportions or median (IQR)

a p < 0.05 versus de-escalation

bSOFA score of 3 or 4 for each organ

# p < 0.05 versus escalation